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Abstract Recently, it has been reported that using multiple
signals, murine and human B cells secrete several cytokines
with pro-inflammatory and immunoregulatory properties. We
present the first comprehensive analysis of 24 cytokines,
chemokines, and hematopoietic growth factors production by
purified human peripheral blood B cells (CD19+), and naive
(CD19+CD27-) and memory (CD19+CD27+) B cells in
response to direct and exclusive signaling provided by toll-
like receptor (TLR) ligands Pam3CSK (TLR1/TLR2), Imi-
quimod (TLR7), and GpG-ODN2006 (TLR9). All three TLR
ligands stimulated B cells (CD19+) to produce cytokines
IL-1α,I L - 1 β,I L - 6 ,T N F - α, IL-13, and IL-10, and chemo-
kines MIP-1α,M I P - 1 β, MCP-1, IP-10, and IL-8. However,
GM-CSF and G-CSF production was predominantly induced
by TLR2 agonist. Most cytokines/chemokines/hematopoietic
growth factors were predominantly or exclusively produced
by memory B cells, and in general, TLR2 signal was more
powerful than signal provided viaTLR7 and TLR9. No
significant secretion of eotaxin, IFN-α,I F N - γ, IL-2, IL-3,
IL-4,IL-5,IL-7,IL-15,IL-17,IL-12p40,IL-12p70,andTNF-β
(lymphotoxin) was observed. These data demonstrate that
human B cells can be directly activated viaTLR1/TLR2,
TLR7, and TLR9 to induce secretion of cytokines, chemo-
kines, and hematopoietic growth factors and suggest a role of
B cells in immune response against microbial pathogenesis
and immune homeostasis.
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Introduction
B lymphocytes are known for their role in adaptive immunity
asspecificantibody-producingcells andasantigen-presenting
cells. More recently, a regulatory role of B cells has been
established, which appears to be mediated by IL-10 secreted
by B cells [1–5]. Furthermore, murine and human B cells
have been shown to produce a number of cytokines, which
require multiple signals, suggesting their role in innate
immunity [6–11]. The toll-like receptors (TLRs) is a family
of transmembrane proteins with an extracellular leucin-rich
domain and a conserved cytoplasmic domain, which is
homologous to the IL-1 receptor [12–14]. Each TLR
recognizes specific microbial components termed pathogen-
associated molecular patterns including bacterial lipoproteins
and peptidoglycan (TLR2), uridine-rich single-stranded ribo-
nucleic acid (ssRNA; TLR7), and microbial deoxyribonucleic
acid (DNA; TLR9) [13, 14]. Recently, several TLRs have
been reported to be present in B cells [15, 16]. Cognasse et al.
[18] have reported secretion of IL-6 by TLR9 expressing
memory B cells. Mansson et al. [17] also reported secretion of
IL-6 via activation of B cells with IL-2, IL-10, recombinant
CD40 ligand, and TLR2, TLR7, and TLR9 ligands.
In this study, we examined the effects of direct signaling
by TLR ligands Pam3CSK4 (TLR1/TLR2), Imiquimod
(TLR7), and CpG-ODN2006 (TLR9) on B cell-derived 24
cytokines, chemokines, and hematopoietic growth factor
production. We observed that all three ligands activated B
cells and induced secretion of 11 of 24 cytokines and
chemokines, whereas hematopoietic growth factor produc-
tion was induced predominantly by TLR1/TLR2 ligand.
Furthermore, the majority of cytokines, chemokines, and
hematopoietic growth factors are predominantly or exclu-
sively produced by CD19+CD27+ memory B cells, and in
general TLR2 was a stronger signal than TLR7 and TLR9
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this is the first report of comprehensive analysis of
secretion of cytokines, chemokines, and hematopoietic
growth factors by direct activation of human naive and
memory B cells by TLR ligands. Our data supports a role of
B cells in innate immune response against microbial
pathogens and immune homeostasis.
Materials and Methods
Subject
Peripheralbloodwasobtainedfromyounghealthyvolunteers.
Protocol was approved by Human Subject Institution Review
Board of the University of California, Irvine.
Reagents
The following monoclonal antibodies and their isotype
controls were used — Peridinin chlorophyll protein PerCP-
conjugated anti-CD19, PE-conjugated anti-CD27, fluorescein
isothiocyanate (FITC)-conjugated anti-CD80, PE-conjugated
anti-CD86, PerCP-conjugated anti-HLADR, and APC-
conjugated anti-CD25, all purchased from BD Pharmingen
(San Jose, CA). B cell enrichment kit was purchased from
Stem Cell Technologies (Vancouver, BC, Canada). TLR
agonist: Pam3CSK4 (TLR1/TLR2), Imiquimod (TLR7), and
CpG-ODN2006 (TLR9) were purchased from InvivoGen
(San Diego , California).
Purification of B Cells and B Cell Subsets
B lymphocytes were purified by immunomagnetic human B
cell enrichment Kit according to manufacturer’s instructions.
Inbrief,peripheralbloodmononuclearcellsweresuspendedat
no more than 1×10
8 cells/ml in PBS containing 2% FBS.
Negative selection cocktail (100 μl/ml) is added and
incubated at room temperature for 15 min. Then the magnetic
nanoparticles are added at 50 μl/ml cells and incubated for
10 min. Cells are placed in a 12×75 mm polystyrene tube at
a volume of 2.5 ml/tube and placed into the magnet for
5 min. The magnetisinvertedandthesupernatantwas poured
off.The magneticlabeledunwantedcells remainboundinside
the original tube. The purity of negatively selected cells was
assessed by flow cytometry (>97%) as detected by the
presence of CD20. Furthermore, during the process of
purification, B cells were not activated as determined by the
expression ofCD80,CD86, CD25, and HLA-DR inB cells in
whole peripheral blood and in the purified B cells.
Purified B cells were further separated into CD27+
(memory) and CD27- (naive) B cells using PE selection kit
(Stem Cell Technologies). Briefly, B cells were labeled with
PE-conjugated anti-CD27antibody. The labeled cells were
incubated with bispecific tetrameric antibody complexes
that recognize PE-labeled cells and dextran. After a 15-min
incubation at room temperature, dextran-coated magnetic
nanoparticles were added, and magnetically labeled cells
(CD27+) were separated from unlabeled cells (CD27-)
using a magnet.
Immunophenotyping
Purified B cells were stimulated with Pam3CSK4 (Pam),
Imiquimod (ImQ), and CpG for 24 h. Cells are stained with
PerCP-conjugated anti-HLA-DR, APC-conjugated anti-
CD25, FITC-conjugated anti-CD80, and PE-conjugated
anti-CD86 antibodies, and isotype controls. After staining,
cells were washed extensively with phosphate buffered
saline and analyzed by FACScalibur (Becton-Dickenson,
San Jose, CA) equipped with argon ion laser emitting at
488 nm [for FITC, phycoerythrin (PE), and PerCP
excitation] and a spatially separate diode laser emitting at
631 nm(for APC excitation). Forward and side scatters
were used to gate and exclude cellular debris. Ten thousand
cells were acquired and analyzed by FloJo software.
Measurement of Cytokines/Chemokines/Hematopoietic
Growth Factors
Cytokine/chemokines secretion was measured in purified
total B cells (CD19+) and purified CD19+CD27+ and
CD19+CD27- B cell subsets by multiplex biomarker
immunoassay. Cells were activated by various concentra-
tions of TLR2, TLR 7, and TLR 9 agonists for 24 h.
Supernatant were collected and stored at -20°C until
assayed. Cytokines/chemokines were detected by Millipore
(St. Charles, MO) MILLIPLEX™ MAP human cytokine/
chemokine kit. Following 26 human cytokines, chemokines
and hematopoietic growth factors were analyzed: Eotaxin,
G-CSF, GM-CSF, IFNα2, INFγ,IL-1α, IL-1β, IL-2, IL-3,
IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 (p40), IL-12
(p70),IL-13,IL-15,IL-17,IP-10(CXCL10),MCP-1,MIP-1α,
MIP-1βb, TNFα,a n dT N F β. MILLIPLEX™ MAP is based
onthe Luminex® xMAP® technology thatusesa technique to
internally color-code microspheres with two fluorescent dyes.
Through precise concentrations of these dyes, 100 distinctly
colored bead sets can be created, each of which is coated with
aspecificcaptureantibody.Afterananalytefromatestsample
is captured by the bead, a biotinylated detection antibody is
introduced in the reaction mixture, which is then incubated
with streptavidin–PE conjugate, the reporter molecule, to
complete the reaction on the surface of each microsphere. The
microspheres are allowed to pass rapidly through a laser
which excites the internal dyes marking the microsphere set.
A second laser excites PE, the fluorescent dye on the reporter
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tify each individual microsphere and quantify the result of its
bioassay based on fluorescent reporter signals. The capability
of adding multiple conjugated beads to each sample results in
the ability to obtain multiple results from each sample.
Statistical analyses were performed by analysis of variance
(ANOVA), and significance was considered at P<0.05.
Results
Purified B Cells are Activated by TLR Ligands
Purified CD19+ B cells were stimulated with two different
concentrations (determined by concentration kinetic stud-
ies) of Pam, ImQ, and CpG for 24 h. At the end of culture,
cells were washed and stained with FITC-anti-CD80, PE-
anti-CD86, PerCP-HLA-DR, and APC-anti-CD25 or iso-
type controls for 30 min on ice. Cells were then washed and
examined for the expression of these activation and co-
stimulatory antigens with multicolor flow cytometry using
FACSCalibur. Ten thousand cells were acquired and
analyzed by FlowJo software. Figure 1a displays a
representative cytograph, and Fig. 1b shows cumulative
data for fluorescence intensity (MFC#, mean±sd) from
three separate experiments using three separate normal
young subjects. All three TLR ligands significantly (P<
0.05-P<0.001) upregulated expression of CD80, CD86,
and CD25; ImQ did not upregulate HLA-DR expression (P>
0.05). It is also apparent that different TLR ligands
upregulated activation antigens to different extent. CD80,
HLA-DR, and CD25 were activated to a greater extent (P<
0.05) by Pam and CpG as compared to ImQ, whereas CD86
was upregulated to a greater extent (P<0.05) by Pam and
ImQ than by CpG.
TLR Ligands Induced Secretion of Pro-Inflammatory
and Anti-Inflammatory/Immunoregulatory Cytokines
Purified B cells were activated with Pam, ImQ, and CpG
as described above for 24 h, supernatants were collected
and stored at -20°C until analyzed. Cytokines were
analyzed by multiplex biomarker immunoassay and data
are expressed (in pg/ml as mean±sd of three separate
experiments). Figure 2a shows data of pro-inflammatory
cytokines IL-1α,I L - 1 β,I L - 6 ,a n dT N F - α. Although all
three TLR ligands induced their secretion, Pam induced
significantly greater amount of IL-6 (P<0.01) as com-
p a r e dt oI L - 6p r o d u c e db yI m Qa n dC p G .C p Gf a i l e dt o
induce secretion of IL-1β. All three ligands induced
secretion of immunoregulatory IL-10 (Fig. 2b), whereas
Pam induced the secretion of anti-inflammatory and
immunoregulatory IL-13 (Fig. 2c).
TLR Ligands Induced Secretion of Chemokines
Purified B cells were activated by Pam, ImQ, and CpG as
described above, and supernatants were analyzed for
chemokines. All three TLR ligands induced secretion of
MIP-1α and IP-10; however, IL-8 was not induced by
CpG, and MCP1 was not significantly induced by any of
the TLR ligands (Fig. 3).
TLR1/TLR2 Ligand Induces Secretion of GM-CSF
and G-CSF
Supernatants from B cells activated with Pam, ImQ, and CpG
were analyzed for the secretion of GM-CSF and G-CSF. Both
growth factors were produced predominantly by TLR1/TRL2
ligand Pam (Fig. 4).
TLR Ligands did Induce Secretion of Multiple Cytokines
None of the TLR ligands induced significant secretions of
eotaxin, IFN-α, IFN-γ,I L - 1 β, IL-2, IL-3, IL-4, IL-5, IL-7,
IL-15, IL-17, IL-12p40, IL-12p70, and TNF-β (data not
shown). This suggests that either priming of B cells by
other signal may be required for TLRs to induce secretion
of these cytokines, or B cells do not produce these
cytokines regardless of the nature and multiplicity of
signals.
Next, we investigated whether naive and memory B cells
respond differently to TLRs signaling. Therefore, we
purified total (CD19+) B cells into naive (CD27-) and
memory (CD27+) B cells and stimulated with TLR ligands
as described above, and supernatants were analyzed for
cytokines, chemokines, and hematopoietic growth factors.
Cytokine Production by Naive and Memory B Cells
Significantly (P<0.5) greater amounts of IL-1α,I L - 1 β,I L - 6 ,
and TNFα were produced by memory B cells upon
stimulation with Pam as compared to naive B cells (Fig. 5a).
ImQ induced significantly greater amounts of IL-1β, and IL-6
in memory B cells as compared to naive B cells. CpG induced
significantly greater amounts (P<0.05) of IL-1α by the
memory B cells as compared to naive B cells. Immunoreg-
ulatory IL-10 was induced by all three ligands in both naive
and memory B cells but significantly more (P<0.05) by
memory B cells as compared to naive B ells in response to
Pam (Fig. 5b). IL-13 was produced by both naive and
memory B cells predominantly in response to Pam (Fig. 5c).
Chemokines Produced by Naive and Memory B Cells
Both naive and memory B cells produced IP-10, IL-8,
MCP-1, MIP-1α, and MIP1β in response to Pam, ImQ, and
J Clin Immunol (2011) 31:89–98 91Fig. 1 TLR-induced activation
of B cells. Purified B cells were
stimulated by 5 μg/ml and
10 μg/ml of TLR1/TLR2 (Pam),
TLR7 (ImQ), and TLR9 (CpG)
ligands for 24 h and co-
stimulatory and activation mol-
ecules were analyzed by multi-
color flow cytometry. a.
Representative cytoflourograph.
b. Cumulative data from three
experiments from three healthy
individuals
92 J Clin Immunol (2011) 31:89–98CpG (Fig. 6). However, Pam induced significantly greater
(P<0.05) amounts of MIP1α and MIP1β by memory B
cells as compared to naive B cells.
Hematopoietic Growth Factor Production by Naive
and Memory B Cells
Both G-CSF and GM-CSF were predominantly produced by
memory B cells upon signaling with Pam and ImQ. CpG failed
to induce significant amounts of G-CSF and GM-CSF (Fig. 7).
Discussion
Although a role of B cells in antibody response and antigen
presentation is well known, its role in innate immune
response and immune regulation has recently been appre-
ciated [6–12]. Recently, B cells have been reported to
express a number of TLRs [15–20]. In mice and most
human studies, cytokine production by B cells utilized
multiple signals including BCR, CD40L, and TLR;
however, cytokine production by B cells in response to
primary and sole signaling by TLR has not been studied in
detail. In this study, we have demonstrated that human B
cells and B cell subsets (naive and memory) may be
directly activated by TLR1/TLR2, TLR7, and TLR9
ligands to induced expression of co-stimulatory antigens
and secretion of 11 of 24 cytokines, chemokines, and
hematopoietic growth factors studied. A number of inves-
tigators have reported that human B cells require priming by
another ligand to be sensitive to TLR signaling [6–12];
however, this may be a matter of end-point assay measured.
Fig. 2 TLR-induced cytokines
(interleukins) production by B
cells. Purified B cells were
stimulated as in Fig. 1. Super-
natants were collected and
examined for cytokine produc-
tion by multiplex biomarker
immunoassay. Data are
expressed as mean±sd from
three separate experiments. All
TLRs, although to different
levels, induced secretion of
proinflammatory cytokines
IL-1α, IL-1β, IL-6, and TNF-α
(a). Immunoregulatory IL-10 (b)
IL-13 were also secreted by B
cells; however, IL-13
secretion was secreted in low
amounts and almost exclusively
by TLR1/TLR2 stimulation (c)
J Clin Immunol (2011) 31:89–98 93In the majority of these reports, B cell proliferation and
differentiation into memory and plasma cells were assays,
whereas in our study, an early event of cytokine/chemokine
secretion was assayed. Therefore, it is likely that B cells may
be directly activated via TLR1/TLR2, TLR7, and TLR9 to
secrete cytokines/chemokines/hematopoietic growth factors
and to upregulate co-stimulatory molecules and antigen-
presenting function. However, they may require more than
one signal to induce cell division and differentiation into
memory and plasma cells.
We observed that TLR1/TLR2 and TLR9 agonists signifi-
cantly upregulated the expression of CD80, CD86, HLA-DR,
and CD25. TLR7 agonist upregulated CD80, CD86, and CD25
but failed to upregulate HLA-DR. It remains to be determined
Fig. 3 TLR-induced production
of chemokines. Purified B cells
were stimulated as in Fig. 1.
Supernatants were collected and
examined for chemokines pro-
duction. All three TLRs induced
secretion of MIP-1α and IP-10
(CXCL3); however, secretion of
MIP-1β, MCP-1, and IL-8 by
various TLR ligands was
variable
Fig. 4 TLR-induced production
of hematopoietic growth factors
by B cells. Purified B cells were
stimulated as in Fig. 1.S u p e r -
natants were collected and
examined for the production of
G-CSF and GM-CSF by multi-
plex biomarker immunoassay.
Both G-CSF and GM-CSF were
produced predominantly in
response to TLR1/TLR2 agonist
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the failure to augment antigen-presenting function of B cells.
Krieg et al. [21] reported that CpG stimulation augments the
expression of CD80, CD86, and HLA-DR in murine B cells,
and Jiang et al. [22] have reported that CpG stimulates naive
B cells to undergo proliferation and enhanced antigen-
presenting function; however, CpG did induce differentiation
into memory B cells or immunoglobulin (Ig)-secreting plasma
cells.
It has been reported that murine B cells are strongly
responsive to direct stimulation with TLR2 ligand [22];
however, human B cells require priming for TLR2 ligand
by cross-linking of the BCR with anti-Ig or protein A [8, 23].
In the present study, we demonstrate that human B cells and
B cell subsets can be directly activated without priming to
secrete cytokines, chemokines, and hematopoietic growth
factors. The reason for this discrepancy may be due to
differences in assays for B cells activation used. Bekeredjian-
Ding et al. [24] used B cell proliferation assay, a much later
event as compared to cytokine and chemokines secretion.
Human B cells also express TLR7 and TLR9 [18, 19]. In
human B cells, TLR7 expression is IFN type I dependent,
which sensitized human B cells for signaling via TLR7
[24]. Therefore, for B cells to respond toTLR7 ligand, B
cells require priming by IFN type I produced by dendritic
cells [25]. However, our data demonstrate that human B
cells and naive and memory B cell subsets can be
stimulated directly by TLR7 agonist without prior sensiti-
zation to secrete cytokines and chemokines. Since our data
show that IFNs are not produced by human B cells, our
study also excludes any possibility of IFN type I produced
by B cells to sensitize B cells to respond to TLR7 ligand in
an autocrine or paracrine manner. We also show that direct
activation of B cells and B cell subsets by CpG (TLR9)
induces secretion of chemokines and cytokines. Hornung et
al. [19] has also reported direct responsiveness of human B
Fig. 5 TLR-induced cytokines
(interleukins) produced by naive
and memory B cells. Purified B
cells were further separated into
naive (CD27-) and memory
(CD27+) B cells and stimulated
with TLR ligands as described in
Fig. 1. Data are expressed as
mean±sd from three separate
experiments. All four pro-
inflammatory cytokines (IL-1α,
IL-1β, TNF-α,a n dIL-6) were
produced predominantly by
memory B cells, in response to
all three TLRs ligands (a).
Immunoregulatory IL-10 was
produced by both naive and
memory B cells by all three
TLRs; however, significantly
(P<0.01) more by memory B
cells in response to TLR1/TLR2
stimulation (b). In contrast,
similar levels of immunoregula-
tory IL-13 were produced by
naive and memory B cells and
almost exclusively by TLR1/
TLR2 stimulation (c)
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expression of TLR7 and TLR9. Cognasse et al. [18]
reported that TLR9+ purified B cells secrete IL-6 upon
stimulation with IL-2, IL-10, soluble CD40L, and TLR9
ligandCpG.Duddyetal.[10],usingBCRandCD40signaling
system, showed that memory B cells produce TNF-α and
lymphotoxin (TNF-β). We also observed that all three TLR
agonists induce TNF-α but not TNF-β,s u g g e s t i n gt h a tt h e
Fig. 6 TLR-induced production
of chemokines by naive and
memory B cells. Purified B cells
were further separated into naive
(CD27-) and memory (CD27+)
B cells and stimulated with TLR
ligands as described in Fig. 1.
All TLRs induced chemokines
production by both naive and
memory B cells
Fig. 7 TLR-induced production of hematopoietic growth factors by
naive and memory B cells. Purified B cells were further separated into
naive (CD27-) and memory (CD27+) B cells and stimulated with TLR
ligands as described in Fig. 1. TLR1/TLR2 and TLR7 induced G-CSF
and GM-CSF secretion almost exclusively by memory B cells. TLR9
stimulations did not induce secretion of either growth factor
96 J Clin Immunol (2011) 31:89–98nature of the signal may dictate the profile of certain cytokine
production by B cells.
A role of B cells in the regulation of T cell responses has
been reported, especially in murine models [1–5]. This
appears to be mediated predominantly by IL-10 [3, 4, 26].
We have also observed that significant amounts of IL-10 is
produced by purified B cells stimulated with all three TLR
agonists Pam, ImQ, and CpG. This is in agreement with
reported IL-10 production in response to TLR9 ligand [6];
however, there are no reports of IL-10 production in
response to TLR1/TLR2 and TLR7. Duddy et al. [10]
reported that IL-10 is produced exclusively by naive B cells
when stimulated by BCR and CD40-mediated signaling.
Recently, Blair et al. [27] reported production of IL-10 by
stimulation of CD19hi+CD24+CD38+hi, a subset of naive B
cells by CD40 ligation. However, no IL-10 was produced by
three different subsets of B cells upon stimulation with anti-
IgM, anti-IgM plus CHO-CD154 cells. This would suggest
that B cell subsets produce different amounts of cytokines
depending upon type of signal. Here, we show that memory
B cells produce significantly greater amounts of IL-10 by
memory B cells especially upon stimulation with TLR1/
TLR2 agonist. Production of IL-10 by B cells via TLR-
mediated mechanism may have evolved as a mechanism to
protect against development of microbial pathogen-induced
chronic inflammatory states, or else microbes use this
mechanism for their persistence in the host by inducing
suppression of immune response. Since IL-10 can induce the
differentiation of B cell to antibody-producing plasma-like
cells, production of endogenous IL-10 may be also a means
to induce the production of antimicrobial antibodies by
antigen-specific B cells. Giordani et al. [28]h a v er e p o r t e d
that INF-α amplifies human naive B cells, TLR-9-mediated
activation, and Ig production. However, Hanten et al. [29]
reported IgG and IgM production by human B cells
following direct activation by TLR ligand without the
presence of IFN-α. Zhang et al. [30] reported that type I
interferons protect neonates from acute inflammation
through IL-10-producing B cells; however, type I interferon
do not potentiate IL-10 production by adult B cells. It is
interesting to note that we have observed that type I
interferon responsive cytokine IP-10 [31] is induced by all
TLR agonists; however, B cells did not secrete IFN-α in
response to any of three TLR agonists. Taken together, it is
likely that IP-10 and IL-10 are produced in direct response to
TLR stimulation rather than induced indirectly by type I
interferon, and naive B cells can be activated directly by
TLRs to differentiate and induce Ig secretion.
IL-13 is an immunoregulatory cytokine secreted predom-
inantlybyactivated T-helper type2cells [32].This cytokine is
involved in several stages of B-cell maturation and differen-
tiation. It upregulates CD23 and MHC class II expression
and promotes IgE isotype switching of B cells. In contrast,
IL-13 downregulates macrophage activity, thereby inhibiting
the production of pro-inflammatory cytokines and chemo-
kines, and appears to be critical to the pathogenesis of
allergen-induced asthma through IgE-independent mecha-
nisms. We observed that B cells, and both naive and memory
B cells, secrete IL-13, which is induced predominantly and
almost exclusively by TLR-2 ligand.
In this study, we also show that direct activation of total
B cells, naive B cells, and memory B cells with TLR1/
TLR2, TLR7, and TLR9 agonists resulted in the secretion
of chemokines IL-8, IP-10, MCP1, MIP1α, and MIP1β.
Furthermore, TLR1/TLR2 signal induced significantly
greater amounts of MIP1α and MIP1β by memory B cells
as compared to naive B cells. IP-10 (CXCL10) was initially
identified as a 10 kD inflammatory chemokine that is
induced by IFN-γ and secreted by various cell types,
including monocytes, neutrophils, endothelial cells, kerati-
nocyte, fibroblasts, mesenchymal cells, dendritic cells, and
astrocytes [33]. IP-10 suppresses neovascularization and
functions as an “angiostatic” chemokine [34]. CXCL10
binds to CXCR3 and regulates immune responses by
activation and recruitment of leukocytes such as T cells,
eosinophils, monocytes, and NK cells [31]. Recent reports
have shown that the serum and/or the tissue expressions of
CXCL10 are increased in various autoimmune diseases
[31]. This would suggest that B cells, in addition to
producing autoantibodies, may play a role in autoimmune
disease through production of chemokines and cytokines.
Our data also suggest that B cells may play an important
role (via secretion of IP-10) in leukocyte homing to
inflamed tissues and in the perpetuation of inflammation
and thus may importantly contribute to tissue damage.
MIP-1α (CCL-3L1) is a most potent ligand for CCR5, the
major co-receptorforHIV,andisadominantHIV-suppressive
cytokines [35]. We show that TLRs directly activate B cells
and B cell subsets to produce large amounts of MIP-1α.I t
remains to be determined whether B cells via secretion of
MIP-1α regulate HIV infection and HIV replication.
G-CSF and GM-CSF are two hematopoietic growth
factors that play an important role on hematopoiesis [36].
We show that direct activation of B cells and memory B
cells greater than naive B cells via TLR2, and to a minor
extent via TLR7, results in the secretion of both GM-CSF
and G-CSF. Therefore, it is likely that B cells might
regulate hematopoiesis, especially in response to TLR2
stimulation (bacterial lipoprotein and lipoteochoic acid).
In summary, signaling via TLR1/TLR2, TLR7, and TLR9
directly activates B cells to secrete proinflammatory and
immunoregulatory cytokines and chemokines. In general,
memoryBcellsappeartosecretegreateramountsofcytokines
and chemokines, and TLR1/TLR2 appear to mediate stronger
signals as compared to the signals provided by TLR7 and
TLR9. Therefore, B cells, in addition to their well-established
J Clin Immunol (2011) 31:89–98 97role in adaptive immunity, may also regulate immune
responses to infectious pathogens via production of cytokines
and chemokines and in immune homeostasis through produc-
tion of immunoregulatory cytokines.
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